Growth investing
Definition
Growth investing
Growth investing is an equity strategy that targets companies expected to expand revenue and earnings faster than the market. Investors accept higher volatility and thin dividends for the chance of outsized capital appreciation over three to five years or longer.
Key takeaways
- Growth investing prioritises capital appreciation over income, so most growth stocks pay little or no dividend.
- Growth stocks typically trade at above-market price-to-earnings ratios because buyers price in future earnings, not current cash flow.
- Sector tilt runs heavy on technology, biotech, and consumer internet, staying sensitive to interest rate moves.
- The style pairs with value investing to balance a portfolio across cycles.
- Concentration risk is real: Peloton and Zoom shed more than 70% of value in 2022.
Growth investors buy the promise of tomorrow’s earnings at today’s price. That means paying a premium multiple upfront and holding through drawdowns while the underlying business compounds.
The trade-off is asymmetry — winners can multiply, but a stalled growth thesis can produce a steep capital loss. Position sizing and diversification matter more than most retail investors assume.
Time horizon separates growth from speculation. A three-to-five-year hold lets compounding do the work, while day-trading a growth stock exposes you to earnings-report volatility that can gap 10-15% overnight.
How it works
Growth investors screen for companies posting sustained double-digit revenue or earnings growth, then hold as the business compounds. Multiples stay elevated because buyers pay for future cash flow, not today’s book value.
The Corporate Finance Institute defines a growth stock as one expected to outpace the average rate of market growth. The screen typically looks at three inputs: revenue growth rate, earnings-per-share trajectory, and return on invested capital.
Position sizing follows a barbell. Most growth funds concentrate 40-60% of assets in the top ten holdings, then diversify the tail across 40-80 mid-cap names to catch the next winner early without single-name blow-up risk.
Style differs sharply from its cousin below.
| Factor | Growth investing | Value investing |
|---|---|---|
| Return source | Capital appreciation | Dividends plus price reversion |
| Typical P/E | Above market average | Below market average |
| Dividend yield | Low or zero | Higher than market |
| Sector tilt | Tech, biotech, consumer internet | Financials, energy, industrials |
| Rate sensitivity | High | Lower |
FTSE Russell’s June 2026 Russell reconstitution flagged renewed style rotation between growth and value indexes, a reminder the label a stock carries can flip year to year.
The US Securities and Exchange Commission publishes plain-English guidance on the equity products underneath both styles.
Growth style historically outperforms during low-rate expansions and underperforms when the Fed hikes. The 2022 selloff wiped 33% off the Nasdaq-100 in a single year as terminal-rate expectations climbed, illustrating the rate-sensitivity trade in real time.
Examples
Real portfolios show the range — from mega-cap technology to niche biotech names that swing 40% in a quarter. The Magnificent Seven anchor most modern growth strategies, but the tail matters too.
The Magnificent Seven (Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia, and Tesla) drove a disproportionate share of S&P 500 returns through 2023 and 2024, making them the archetype for large-cap growth allocations.
Peloton and Zoom are the cautionary examples. Both looked like durable growth winners in 2021 before revenue normalised post-pandemic and share prices lost more than 70% by 2022. The lesson: a growth thesis can break faster than the multiple contracts.
Outside the US, ASML in the Netherlands and Novo Nordisk in Denmark rank among the best-performing global growth names of the last decade. Both compound through pricing power and single-digit annual volume growth.
Retail-facing growth stories like Chipotle and Costco also fit the profile — same-store sales growth in high single-digits, aggressive unit expansion, and premium multiples that reward operational execution over five to ten years.
Biotech growth carries binary risk. Companies like Vertex Pharmaceuticals compound quietly on approved-drug royalties, while smaller names live or die on phase-3 trial readouts — a single failed endpoint can erase half the market cap in a day.
For index exposure, Vanguard Growth ETF (VUG) and iShares Russell 1000 Growth ETF (IWF) hold the largest US growth names by market cap and rebalance annually.
Research shops such as Morningstar publish style-box classifications showing where each fund sits on the growth-value axis.
Related terms
- Value investing: buying companies trading below intrinsic value, the philosophical opposite of growth.
- Growth stock: the individual security that populates a growth portfolio.
- Dividend: the cash payout most growth companies deliberately skip to reinvest in expansion.
- Asset allocation: the portfolio-level decision on how much capital sits in growth versus other styles.
- Bond: the fixed-income counterweight most growth-heavy portfolios pair with for stability.
- Capital loss: the realised downside when a growth thesis breaks and shares are sold below cost.
FAQ
What is the main goal of growth investing?
The main goal is capital appreciation. Growth investors buy shares of companies expected to grow earnings faster than the market and rely on rising share prices, not dividends, for returns.
How is growth investing different from value investing?
Growth investing pays a premium for future earnings and tolerates thin dividends. Value investing hunts for shares trading below intrinsic worth, often with higher dividend yields and lower price-to-earnings ratios.
Is growth investing riskier than other styles?
Yes, on average. Growth stocks carry higher valuations, so drawdowns during rate hikes or missed earnings can be sharper. Diversification and a multi-year horizon soften the swings.
Who should consider growth investing?
Investors with a long time horizon, tolerance for volatility, and no immediate need for portfolio income are the best fit. It suits younger investors building wealth more than retirees drawing down.
How do I start growth investing?
Start with a low-cost growth index fund or ETF for diversified exposure, then add individual positions only after you can articulate each company’s growth thesis in one paragraph.
Do growth stocks pay dividends?
Most do not. Growth companies reinvest earnings into R&D, hiring, and acquisitions rather than payouts, so yields sit close to zero across large US growth names.
Explore more OA terms and guidance at Outsource Accelerator
Independent
